AB-101 / Arbutus  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AB-101 / Arbutus
NCT05960240: Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Recruiting
1
164
RoW
AB-101, Placebo, Nucleos(t)ide Analogue
Arbutus Biopharma Corporation
Chronic Hepatitis b
12/26
04/27

Download Options